14.BETA.,17-ALPHA-HYDROXYMETHYLANDROSTANE DERIVATIVES AS ANDROGENS
申请人:Akzo Nobel N.V.
公开号:EP1163259B1
公开(公告)日:2002-11-20
US6881728B1
申请人:——
公开号:US6881728B1
公开(公告)日:2005-04-19
[EN] 14.BETA., 17-ALPHA-HYDROXYMETHYLANDROSTANE DERIVATIVES AS ANDROGENS<br/>[FR] DERIVES DE 14.BETA., ALPHA-HYDROXYMETHYLANDROSTANE INTERVENANT COMME ANDROGENES
申请人:AKZO NOBEL NV
公开号:WO2000053619A1
公开(公告)日:2000-09-14
The disclosed invention relates to the unexpected finding of steroids for use as androgens which are characterized by a configuration opposite to that of natural steroids, viz. 14α, 17β. These steroids according to the invention are (14β, 17α)-17-(hydroxymethyl) steroids, and they are found to have in common an androgenic activity. They can be used for the preparation of an agent for male contraception, as well as for the preparation of a medicament for the treatment of androgen insufficiency.